Literature DB >> 24535483

[Medicinal treatment of atrial fibrillation in special situations].

Dietrich Pfeiffer1, Daniel Jurisch, Jens-Gerrit Kluge, Andreas Hagendorff, Norbert Klein.   

Abstract

The treatment of atrial fibrillation has to take into account the underlying cardiac and extracardiac diseases. A successful treatment of the underlying disease will only be sufficient treatment of atrial fibrillation in very rare situations. Therefore, this review focuses on the consequences of underlying heart disease, the hemodynamics and concomitant clinical situations on the treatment of atrial fibrillation.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24535483     DOI： 10.1007/s00399-014-0301-2

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


  24 in total

1.  Atrial fibrillation in athletes and the interplay between exercise and health.

Authors:  Andre La Gerche; Christian Marc Schmied
Journal:  Eur Heart J       Date:  2013-07-24       Impact factor: 29.983

Review 2.  Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature.

Authors:  Elie Traube; Neil L Coplan
Journal:  Tex Heart Inst J       Date:  2011

3.  Atrial fibrillation in obstructive sleep apnea.

Authors:  Sandeep K Goyal; Abhishek Sharma
Journal:  World J Cardiol       Date:  2013-06-26

4.  Overdrive ventricular pacing in pacemaker recipients with permanent atrial fibrillation and sleep apnea.

Authors:  Philippe Bordier; Sylvie Maurice-Tison; Nishi Krishna Ramana
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

5.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Authors:  Willem J M Dewilde; Tom Oirbans; Freek W A Verheugt; Johannes C Kelder; Bart J G L De Smet; Jean-Paul Herrman; Tom Adriaenssens; Mathias Vrolix; Antonius A C M Heestermans; Marije M Vis; Jan G P Tijsen; Arnoud W van 't Hof; Jurriën M ten Berg
Journal:  Lancet       Date:  2013-02-13       Impact factor: 79.321

6.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Authors:  Stephen Sidney; Michael Sorel; Charles P Quesenberry; Cynthia DeLuise; Stephan Lanes; Mark D Eisner
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

7.  Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.

Authors:  Paolo Alboni; Giovanni L Botto; Nicola Baldi; Mario Luzi; Vitantonio Russo; Lorella Gianfranchi; Paola Marchi; Massimo Calzolari; Alberto Solano; Raffaele Baroffio; Germano Gaggioli
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

8.  Sleep-disordered breathing and chronic atrial fibrillation.

Authors:  B Braga; D Poyares; F Cintra; C Guilleminault; C Cirenza; S Horbach; D Macedo; R Silva; S Tufik; A A V De Paola
Journal:  Sleep Med       Date:  2008-02-14       Impact factor: 3.492

Review 9.  Atrial fibrillation in chronic non-cardiac disease: where do we stand?

Authors:  Mitja Lainscak; Nikolaos Dagres; Gerasimos S Filippatos; Stefan D Anker; Dimitrios Th Kremastinos
Journal:  Int J Cardiol       Date:  2008-03-28       Impact factor: 4.164

10.  Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study.

Authors:  Lars Frost; Peter Vestergaard; Leif Mosekilde
Journal:  Arch Intern Med       Date:  2004 Aug 9-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.